Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: A first step to measure and improve care

Clinical Infectious Diseases

Volumn 46, Issue 5, 2008, Pages 703-711

  Hermanides, H S ^a   Hulscher, M E J L ^b   Schouten, J A ^b   Prins, J M ^a   Geerlings, Suzanne E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HEALTH CARE QUALITY; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; INTERRATER RELIABILITY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; URINARY CATHETER; URINARY TRACT INFECTION; URINE CULTURE; VALIDITY; HOSPITAL; NETHERLANDS;

ANTI-BACTERIAL AGENTS; FEMALE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; MALE; NETHERLANDS; QUALITY INDICATORS, HEALTH CARE; URINARY TRACT INFECTIONS;

EID: 39749155804     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/527384     Document Type: Article

References (23)

1. Sevinc F, Prins JM, Koopmans RP, et al. Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. J Antimicrob Chemother 1999; 43:601-6.
2. Gupta K, Stamm WE. Outcomes associated with trimethoprim/ sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI. Int J Antimicrob Agents 2002; 19:554-6.
3. Neeling de AJ, Verbrugh HA. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Nethmap, 2005.
4. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29:745-58.
5. Naber KG, Bergman B, Bishop MC, et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 2001; 40:576-88.
6. Geerlings SE, van den Broek PJ, van Haarst E, et al. Optimisation of the antibiotic policy in the Netherlands. X. The SWAB guideline for antimicrobial treatment of complicated urinary tract infections. Ned Tijdschr Geneeskd 2006; 150:2370-6.
7. Menendez R, Torres A, Zalacain R, et al. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med 2005; 172:757-62.
8. Frei CR, Restrepo MI, Mortensen EM, Burgess DS. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med 2006; 119:865-71.
9. Lawrence M, Olesen F, et al. Indicators of quality health care. Eur J Gen Pract 1997; 3:103-8.
10. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 1995; 274:1800-4.
11. Rubin HR, Pronovost P, Diette GB. From a process of care to a measure: the development and testing of a quality indicator. Int J Qual Health Care 2001; 13:489-96.
12. Gagliardi AR, Simunovic M, Langer B, Stern H, Brown AD. Development of quality indicators for colorectal cancer surgery, using a 3-step modified Delphi approach. Can J Surg 2005; 48:441-52.
13. Malin JL, Asch SM, Kerr EA, McGlynn EA. Evaluating the quality of cancer care: development of cancer quality indicators for a global quality assessment tool. Cancer 2000; 88:701-7.
14. Campbell SM, Cantrill JA, Roberts D. Prescribing indicators for UK general practice: Delphi consultation study. BMJ 2000; 321:425-8.
15. Shekelle PG, Kahan JP, Bernstein SJ, Leape LL, Kamberg CJ, Park RE. The reproducibility of a method to identify the overuse and under-use of medical procedures. N Engl J Med 1998; 338:1888-95.
16. Mainz J. Developing evidence-based clinical indicators: a state of the art methods primer. Int J Qual Health Care 2003; 15(Suppl 1):5-11.
17. Rubenstein JN, Schaeffer AJ. Managing complicated urinary tract infections: the urologic view. Infect Dis Clin North Am 2003; 17:333-51.
18. Campbell SM, Braspenning J, Hutchinson A, Marshall M. Research methods used in developing and applying quality indicators in primary care. Qual Saf Health Care 2002; 11:358-64.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-74.
20. Schouten JA, Hulscher ME, Wollersheim H, et al. Quality of antibiotic use for lower respiratory tract infections at hospitals: (how) can we measure it? Clin Infect Dis 2005; 41:450-60.
21. Goossens H, Ferech M, Stichele RV, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365:579-87.
22. Campbell SM, Hann M, Roland MO, Quayle JA, Shekelle PG. The effect of panel membership and feedback on ratings in a two-round Delphi survey: results of a randomized controlled trial. Med Care 1999; 37:964-8.
23. Coulter I, Adams A, Shekelle P. Impact of varying panel membership on ratings of appropriateness in consensus panels: a comparison of a multi- and single disciplinary panel. Health Serv Res 1995; 30:577-91.